Gallant Therapeutics announces study for feline stem cell therapyDecember 18, 2023Gallant Therapeutics, an animal health biotechnology company announced the launch of a study to evaluate the safety and efficacy of its novel allogeneic stem cell therapy candidate to support FDA conditional approval in cats with refractory feline chronic gingivostomatitis (FCGS), the JEDI study.
Education Center - SponsoredHow AI-Enabled Diagnostic Platforms are Buying Back Time for Veterinarians and Cliniciansby • Zoetis DiagnosticsIn the right context, AI yields the power to enhance clinical confidence and streamline decision-making – without replacing the human touch that defines the profession.
Pet Business names the top pet products of 2023December 15, 2023With limited space in most veterinary practice’s retail centers, reviewing this year winners is one possible route in determining what to sell or gift clients for referrals.
South Korea eyes an US$11.5 billion pet industry by 2027December 14, 2023South Korea has set a goal to turn its entire pet market into a 15 trillion won industry (approximately US$11.47 billion at present) by 2027 with government-led initiatives to further prepare for its growth, reports Petfood Industry’s website.
VPN Plus+ ExclusiveTech Talk: Don't put your self (care) on the shelfDecember 13, 2023By Jamie Rauscher, LVT
AAHA announces enhanced digital benchmarking platform now free for all membersDecember 13, 2023The American Animal Hospital Association (AAHA) has partnered with Chewy Health to provide its comprehensive analytics platform, AAHA Benchmarking+, free to all members and practices using certain Chewy Health tools.
